Full Text:   <159>

Summary:  <16>

CLC number: 

On-line Access: 2022-07-06

Received: 2021-12-06

Revision Accepted: 2022-03-20

Crosschecked: 2022-07-06

Cited: 0

Clicked: 152

Citations:  Bibtex RefMan EndNote GB/T7714

 ORCID:

Chaochao YU

https://orcid.org/0000-0003-3216-7473

Yingwen ZHANG

https://ORCID:orcid.org/0000-0003-0934-4603

-   Go to

Article info.
Open peer comments

Journal of Zhejiang University SCIENCE B 2022 Vol.23 No.7 P.547-563

http://doi.org/10.1631/jzus.B2101019


Bioactive constituents of animal-derived traditional Chinese medicinal materials for breast cancer: opportunities and challenges


Author(s):  Chaochao YU, Yi LI, Guopeng CHEN, Chaoyan WU, Xiuping WANG, Yingwen ZHANG

Affiliation(s):  Department of Integrated Chinese and Western Medicine, Zhongnan Hospital of Wuhan University, Wuhan University, Wuhan 430071, China; more

Corresponding email(s):   hhao3838@sina.com

Key Words:  Breast cancer, Traditional Chinese medicinal material (TCMM), Bioactive constituent, Anticancer effect


Chaochao YU, Yi LI, Guopeng CHEN, Chaoyan WU, Xiuping WANG, Yingwen ZHANG. Bioactive constituents of animal-derived traditional Chinese medicinal materials for breast cancer: opportunities and challenges[J]. Journal of Zhejiang University Science B, 2022, 23(7): 547-563.

@article{title="Bioactive constituents of animal-derived traditional Chinese medicinal materials for breast cancer: opportunities and challenges",
author="Chaochao YU, Yi LI, Guopeng CHEN, Chaoyan WU, Xiuping WANG, Yingwen ZHANG",
journal="Journal of Zhejiang University Science B",
volume="23",
number="7",
pages="547-563",
year="2022",
publisher="Zhejiang University Press & Springer",
doi="10.1631/jzus.B2101019"
}

%0 Journal Article
%T Bioactive constituents of animal-derived traditional Chinese medicinal materials for breast cancer: opportunities and challenges
%A Chaochao YU
%A Yi LI
%A Guopeng CHEN
%A Chaoyan WU
%A Xiuping WANG
%A Yingwen ZHANG
%J Journal of Zhejiang University SCIENCE B
%V 23
%N 7
%P 547-563
%@ 1673-1581
%D 2022
%I Zhejiang University Press & Springer
%DOI 10.1631/jzus.B2101019

TY - JOUR
T1 - Bioactive constituents of animal-derived traditional Chinese medicinal materials for breast cancer: opportunities and challenges
A1 - Chaochao YU
A1 - Yi LI
A1 - Guopeng CHEN
A1 - Chaoyan WU
A1 - Xiuping WANG
A1 - Yingwen ZHANG
J0 - Journal of Zhejiang University Science B
VL - 23
IS - 7
SP - 547
EP - 563
%@ 1673-1581
Y1 - 2022
PB - Zhejiang University Press & Springer
ER -
DOI - 10.1631/jzus.B2101019


Abstract: 
breast cancer is globally the most common invasive cancer in women and remains one of the leading causes of cancer-related deaths. Surgery, radiotherapy, chemotherapy, immunotherapy, and endocrine therapy are currently the main treatments for this cancer type. However, some breast cancer patients are prone to drug resistance related to chemotherapy or immunotherapy, resulting in limited treatment efficacy. Consequently, traditional Chinese medicinal materials (TCMMs) as natural products have become an attractive source of novel drugs. In this review, we summarized the current knowledge on the active components of animal-derived TCMMs, including Ophiocordyceps sinensis-derived cordycepin, the aqueous and ethanolic extracts of O. sinensis, norcantharidin (NCTD), Chansu, bee venom, deer antlers, Ostrea gigas, and scorpion venom, with reference to marked anti-breast cancer effects due to regulating cell cycle arrest, proliferation, apoptosis, metastasis, and drug resistance. In future studies, the underlying mechanisms for the antitumor effects of these components need to be further investigated by utilizing multi-omics technologies. Furthermore, large-scale clinical trials are necessary to validate the efficacy of bioactive constituents alone or in combination with chemotherapeutic drugs for breast cancer treatment.

动物来源中药活性组分在乳腺癌中的运用:机遇和挑战

余超超1,李怡2,陈国鹏3,吴朝妍1,王秀萍1,张莹雯1
1武汉大学中南医院中西医结合科,中国武汉430071
2武汉大学中南医院肿瘤放化疗科,中国武汉430071
3武汉大学中南医院血液科,中国武汉430071
概要:乳腺癌已成为发病率最高的女性恶性肿瘤之一,严重威胁女性健康。化疗联合手术、放射治疗几乎可用于乳腺癌治疗的各个阶段,但化疗相关耐药性常导致治疗效果有限。传统中药材已成为极具吸引力的新型药物研发来源之一。具有抗乳腺癌效应的中药主要包括中草药类、动物类中药材,近年来关于其抗肿瘤效应的机制研究层出不穷。目前虽有相关综述对抗乳腺癌的中草药进行了讨论分析,而关于动物类来源中药材的抗乳腺癌机制却缺乏系统的总结和分析。本文通过系统地综述和分析,探讨了冬虫夏草来源的虫草素及其水或乙醇提取物、蟾酥、去甲斑蝥素、蜂毒素、鹿茸、牡蛎等中药材可通过调节细胞周期、增殖、凋亡及肿瘤细胞耐药性发挥抗乳腺癌作用。在未来的研究中,需要采用多组学技术进一步研究这些成分的抗乳腺癌作用机制。此外,有必要进行相关临床试验以验证这些动物来源中药活性成分单独或与化疗药物联合治疗乳腺癌的疗效及安全性。

关键词:乳腺癌;中药材;活性成分;抗肿瘤效应

Darkslateblue:Affiliate; Royal Blue:Author; Turquoise:Article

Reference

[1]AdekunleAI, CromerD, DavenportMP, 2016. Artemisinin-based treatments in pregnant women with malaria. N Engl J Med, 375(3):283-284.

[2]AhmadiS, KnerrJM, ArgemiL, et al., 2020. Scorpion venom: detriments and benefits. Biomedicines, 8(5):118.

[3]Al-AsmariAK, RiyasdeenA, IslamM, 2018. Scorpion venom causes upregulation of p53 and downregulation of Bcl-xL and BID protein expression by modulating signaling proteins Erk1/2 and STAT3, and DNA damage in breast and colorectal cancer cell lines. Integr Cancer Ther, 17(2):271-281.

[4]AnJ, MinieM, SasakiT, et al., 2017. Antimalarial drugs as immune modulators: new mechanisms for old drugs. Annu Rev Med, 68:317-330.

[5]BhushanA, GonsalvesA, MenonJU, 2021. Current state of breast cancer diagnosis, treatment, and theranostics. Pharmaceutics, 13(5):723.

[6]BoymanO, Arenas-RamirezN, 2019. Development of a novel class of interleukin-2 immunotherapies for metastatic cancer. Swiss Med Wkly, 149:w14697.

[7]CaiHW, LiJ, GuBH, et al., 2018. Extracts of Cordyceps sinensis inhibit breast cancer cell metastasis via down-regulation of metastasis-related cytokines expression. J Ethnopharmacol, 214:106-112.

[8]CallenderSP, MathewsJA, KobernykK, et al., 2017. Microemulsion utility in pharmaceuticals: implications for multi-drug delivery. Int J Pharm, 526(1-2):425-442.

[9]CaoYT, WuJH, PanHY, et al., 2019. Chemical profile and multicomponent quantitative analysis for the quality evaluation of toad venom from different origins. Molecules, 24(19):3595.

[10]CarpenaM, Nuñez-EstevezB, Soria-LopezA, et al., 2020. Bee venom: an updating review of its bioactive molecules and its health applications. Nutrients, 12(11):3360.

[11]CeremugaM, StelaM, JanikE, et al., 2020. Melittin—a natural peptide from bee venom which induces apoptosis in human leukaemia cells. Biomolecules, 10(2):247.

[12]ChenF, ZhuL, HuJY, et al., 2020. Bufalin attenuates triple-negative breast cancer cell stemness by inhibiting the expression of SOX2/OCT4. Oncol Lett, 20(5):171.

[13]ChenPX, WangSN, NieSP, et al., 2013. Properties of Cordyceps sinensis: a review. J Funct Foods, 5(2):550-569.

[14]ChenYJ, KuoCD, ChenSH, et al., 2012. Small-molecule synthetic compound norcantharidin reverses multi-drug resistance by regulating Sonic hedgehog signaling in human breast cancer cells. PLoS ONE, 7(5):e37006.

[15]ChenYL, BianXL, GuoFJ, et al., 2018. Two new 19-norbufadienolides with cardiotonic activity isolated from the venom of Bufo bufo gargarizans. Fitoterapia, 131:215-220.

[16]ChintalapatiM, TruaxR, StoutR, et al., 2009. In vitro and in vivo anti-angiogenic activities and inhibition of hormone-dependent and -independent breast cancer cells by ceramide methylaminoethylphosphonate. J Agric Food Chem, 57(12):5201-5210.

[17]ChoHJ, JeongYJ, ParkKK, et al., 2010. Bee venom suppresses PMA-mediated MMP-9 gene activation via JNK/p38 and NF-κB-dependent mechanisms. J Ethnopharmacol, 127(3):662-668.

[18]ChoiS, LimMH, KimKM, et al., 2011. Cordycepin-induced apoptosis and autophagy in breast cancer cells are independent of the estrogen receptor. Toxicol Appl Pharmacol, 257(2):165-173.

[19]ChoncoL, Landete-CastillejosT, Serrano-HerasG, et al., 2021. Anti-tumour activity of deer growing antlers and its potential applications in the treatment of malignant gliomas. Sci Rep, 11:42.

[20]CraggGM, PezzutoJM, 2016. Natural products as a vital source for the discovery of cancer chemotherapeutic and chemopreventive agents. Med Princ Pract, 25(Suppl 2):41-59.

[21]DanilukK, KutwinM, GrodzikM, et al., 2019. Use of selected carbon nanoparticles as melittin carriers for MCF-7 and MDA-MB-231 human breast cancer cells. Materials (Basel), 13(1):90.

[22]DemainAL, VaishnavP, 2011. Natural products for cancer chemotherapy. Microb Biotechnol, 4(6):687-699.

[23]DeNardoDG, RuffellB, 2019. Macrophages as regulators of tumour immunity and immunotherapy. Nat Rev Immunol, 19(6):369-382.

[24]DengLJ, QiM, LiN, et al., 2020. Natural products and their derivatives: promising modulators of tumor immunotherapy. J Leukoc Biol, 108(2):493-508.

[25]DeSantisCE, MaJM, GaudetMM, et al., 2019. Breast cancer statistics, 2019. CA Cancer J Clin, 69(6):438-451.

[26]Díaz-GarcíaA, VarelaD, 2020. Voltage-gated K+/Na+ channels and scorpion venom toxins in cancer. Front Pharmacol, 11:913.

[27]DongCH, GuoSP, WangWF, et al., 2015. Cordyceps industry in China. Mycology, 6(2):121-129.

[28]DongYH, YinST, LiJH, et al., 2011. Bufadienolide compounds sensitize human breast cancer cells to TRAIL-induced apoptosis via inhibition of STAT3/Mcl-1 pathway. Apoptosis, 16(4):394-403.

[29]DornDC, KouCA, PngKJ, et al., 2009. The effect of cantharidins on leukemic stem cells. Int J Cancer, 124(9):2186-2199.

[30]DuffyC, SorollaA, WangE, et al., 2020. Honeybee venom and melittin suppress growth factor receptor activation in HER2-enriched and triple-negative breast cancer. NPJ Precis Oncol, 4:24.

[31]DuttaS, MahalanobishS, SahaS, et al., 2019. Natural products: an upcoming therapeutic approach to cancer. Food Chem Toxicol, 128:240-255.

[32]EmensLA, 2018. Breast cancer immunotherapy: facts and hopes. Clin Cancer Res, 24(3):511-520.

[33]FuldaS, 2015. Promises and challenges of Smac mimetics as cancer therapeutics. Clin Cancer Res, 21(22):5030-5036.

[34]GarbayoE, Pascual-GilS, Rodríguez-NogalesC, et al., 2020. Nanomedicine and drug delivery systems in cancer and regenerative medicine. Wiley Interdiscip Rev Nanomed Nanobiotechnol, 12(5):e1637.

[35]GarciaIJP, de OliveiraGC, de Moura ValadaresJM, et al., 2019. New bufadienolides extracted from Rhinella marina inhibit Na,K-ATPase and induce apoptosis by activating caspases 3 and 9 in human breast and ovarian cancer cells. Steroids, 152:108490.

[36]GuoZR, 2016. Artemisinin anti-malarial drugs in China. Acta Pharm Sin B, 6(2):115-124.

[37]HaoY, BakerD, Ten DijkeP, 2019. TGF-β-mediated epithelial-mesenchymal transition and cancer metastasis. Int J Mol Sci, 20(11):2767.

[38]HassanMSU, AnsariJ, SpoonerD, et al., 2010. Chemotherapy for breast cancer (Review). Oncol Rep, 24(5):1121-1131.

[39]HeQ, XueSY, TanYQ, et al., 2019. Dual inhibition of Akt and ERK signaling induces cell senescence in triple-negative breast cancer. Cancer Lett, 448:94-104.

[40]HematyarM, SoleimaniM, Es-HaghiA, et al., 2018. Synergistic co-delivery of doxorubicin and melittin using functionalized magnetic nanoparticles for cancer treatment: loading and in vitro release study by LC-MS/MS. Artif Cells Nanomed Biotechnol, 46(sup3):S1226-S1235.

[41]HsiaTC, YuCC, HsuSC, et al., 2014. Cantharidin induces apoptosis of H460 human lung cancer cells through mitochondria-dependent pathways. Int J Oncol, 45(1):245-254.

[42]HuW, QiL, TianYH, et al., 2015. Studies on the purification of polypeptide from sika antler plate and activities of antitumor. BMC Complement Altern Med, 15:328.

[43]HuangPS, WangXL, LiangXY, et al., 2019. Nano-, micro-, and macroscale drug delivery systems for cancer immunotherapy. Acta Biomater, 85:1-26.

[44]HuangSY, YaoYD, ChenLL, et al., 2010. Anti-invasive and anti-metastasis effect of norcantharidin on high-metastatic human breast cancer cell lines. J Trop Med, 10(9):‍1034-1038 (in Chinese).

[45]HuangY, LiuQ, LiuK, et al., 2009. Suppression of growth of highly-metastatic human breast cancer cells by norcantharidin and its mechanisms of action. Cytotechnology, 59(3):201-208.

[46]HuoYS, HuoH, ZhangJ, 2014. The contribution of deer velvet antler research to the modern biological medicine. Chin J Integr Med, 20(10):723-728.

[47]JeongMH, LeeCM, LeeSW, et al., 2013. Cordycepin-enriched Cordyceps militaris induces immunomodulation and tumor growth delay in mouse-derived breast cancer. Oncol Rep, 30(4):1996-2002.

[48]JeongYJ, ChoiY, ShinJM, et al., 2014. Melittin suppresses EGF-induced cell motility and invasion by inhibiting PI3K/Akt/mTOR signaling pathway in breast cancer cells. Food Chem Toxicol, 68:218-225.

[49]JiangZW, ChiJH, HanBQ, et al., 2017. Preparation and pharmacological evaluation of norcantharidin-conjugated carboxymethyl chitosan in mice bearing hepatocellular carcinoma. Carbohydr Polym, 174:282-290.

[50]JinL, JinLS, WuRJ, et al., 2021. Hirsutella sinensis fungus regulates CD8+ T cell exhaustion through involvement of T-bet/Eomes in the tumor microenvironment. Front Pharmacol, 11:612620.

[51]JinXH, WangJB, ZouS, et al., 2020. Cinobufagin triggers defects in spindle formation and cap-dependent translation in liver cancer cells by inhibiting the AURKA-mTOR-eIF4E axis. Am J Chin Med, 48(3):651-678.

[52]KampoS, AhmmedB, ZhouTT, et al., 2019. Scorpion venom analgesic peptide, BmK AGAP inhibits stemness, and epithelial-mesenchymal transition by down-regulating PTX3 in breast cancer. Front Oncol, 9:21.

[53]KatoT, NishimuraK, SuparminA, et al., 2021. Effects of cordycepin in Cordyceps militaris during its infection to silkworm larvae. Microorganisms, 9(4):681.

[54]KimKH, SeoHS, ChoiHS, et al., 2011. Induction of apoptotic cell death by ursolic acid through mitochondrial death pathway and extrinsic death receptor pathway in MDA-MB-231 cells. Arch Pharm Res, 34(8):1363-1372.

[55]LanYL, LouJC, JiangXW, et al., 2019. A research update on the anticancer effects of bufalin and its derivatives (Review). Oncol Lett, 17(4):3635-3640.

[56]LeeCT, HuangKS, ShawJF, et al., 2020. Trends in the immunomodulatory effects of Cordyceps militaris: total extracts, polysaccharides and cordycepin. Front Pharmacol, 11:575704.

[57]LeeD, LeeWY, JungK, et al., 2019. The inhibitory effect of cordycepin on the proliferation of MCF-7 breast cancer cells, and its mechanism: an investigation using network pharmacology-based analysis. Biomolecules, 9(9):414.

[58]LeeHJ, BurgerP, VogelM, et al., 2012. The nucleoside antagonist cordycepin causes DNA double strand breaks in breast cancer cells. Invest New Drugs, 30(5):1917-1925.

[59]LeeS, LeeY, ChoiYJ, et al., 2014. Cyto-/genotoxic effects of the ethanol extract of Chan Su, a traditional Chinese medicine, in human cancer cell lines. J Ethnopharmacol, 152(2):372-376.

[60]LeiSY, ZhengRS, ZhangSW, et al., 2021. Global patterns of breast cancer incidence and mortality: a population-based cancer registry data analysis from 2000 to 2020. Cancer Commun (Lond), 41(11):1183-1194.

[61]LiCY, 2012. Deer antler regeneration: a stem cell-based epimorphic process. Birth Defects Res C Embryo Today, 96(1):51-62.

[62]LiFJ, HuJH, RenX, et al., 2021. Toad venom: a comprehensive review of chemical constituents, anticancer activities, and mechanisms. Arch Pharm (Weinheim), 354(7):2100060.

[63]LiJ, CaiHW, SunHH, et al., 2020. Extracts of Cordyceps sinensis inhibit breast cancer growth through promoting M1 macrophage polarization via NF-κB pathway activation. J Ethnopharmacol, 260:112969.

[64]LiM, WangXJ, ZhaoQ, et al., 2020. Bufalin-induced cardiotoxicity: new findings into mechanisms. Chin J Nat Med, 18(7):550-560.

[65]LiSP, LiP, DongTTX, et al., 2001. Anti-oxidation activity of different types of natural Cordyceps sinensis and cultured Cordyceps mycelia. Phytomedicine, 8(3):207-212.

[66]LiW, XieL, ChenZ, et al., 2010. Cantharidin, a potent and selective PP2A inhibitor, induces an oxidative stress-independent growth inhibition of pancreatic cancer cells through G2/M cell-cycle arrest and apoptosis. Cancer Sci, 101(5):1226-1233.

[67]LiXT, LiHC, LiCB, et al., 2010. Protective effects on mitochondria and anti-aging activity of polysaccharides from cultivated fruiting bodies of Cordyceps militaris. Am J Chin Med, 38(6):1093-1106.

[68]LiXW, ChenCH, DaiY, et al., 2019. Cinobufagin suppresses colorectal cancer angiogenesis by disrupting the endothelial mammalian target of rapamycin/hypoxia-inducible factor 1α axis. Cancer Sci, 110(5):1724-1734.

[69]LiYF, XiaoYJ, LinHP, et al., 2019. In vivo β-catenin attenuation by the integrin α5-targeting nano-delivery strategy suppresses triple negative breast cancer stemness and metastasis. Biomaterials, 188:160-172.

[70]LiYL, TianX, LiuXD, et al., 2018. Bufalin inhibits human breast cancer tumorigenesis by inducing cell death through the ROS-mediated RIP1/RIP3/PARP-1 pathways. Carcinogenesis, 39(5):700-707.

[71]LiYL, GongPC, KongCC, et al., 2019. Bufalin engages in RIP1-dependent and ROS-dependent programmed necroptosis in breast cancer cells by targeting the RIP1/RIP3/PGAM5 pathway. Anticancer Drugs, 30(7):706-713.

[72]LiaoLX, SongXM, WangLC, et al., 2017. Highly selective inhibition of IMPDH2 provides the basis of antineuroinflammation therapy. Proc Natl Acad Sci USA, 114(29):E5986-E5994.

[73]LinSS, LyuXD, YuJ, et al., 2016. MHP-1 inhibits cancer metastasis and restores topotecan sensitivity via regulating epithelial-mesenchymal transition and TGF-β signaling in human breast cancer cells. Phytomedicine, 23(10):1053-1063.

[74]LinYE, ChenYC, LuKH, et al., 2021. Antidepressant-like effects of water extract of Cordyceps militaris (Linn.) Link by modulation of ROCK2/PTEN/Akt signaling in an unpredictable chronic mild stress-induced animal model. J Ethnopharmacol, 276:114194.

[75]LiuDW, ChenZW, 2009. The effects of cantharidin and cantharidin derivates on tumour cells. Anticancer Agents Med Chem, 9(4):392-396.

[76]LiuDW, ShiPG, YinX, et al., 2012. Effect of norcantharidin on the human breast cancer Bcap-37 cells. Connect Tissue Res, 53(6):508-512.

[77]LiuJY, GengXF, HouJX, et al., 2021. New insights into M1/M2 macrophages: key modulators in cancer progression. Cancer Cell Int, 21:389.

[78]LiuMJ, WangHT, LiuLJ, et al., 2016. Melittin-MIL-2 fusion protein as a candidate for cancer immunotherapy. J Transl Med, 14:155.

[79]MaLN, SongB, JinH, et al., 2012. Cinobufacini induced MDA-MB-231 cell apoptosis-associated cell cycle arrest and cytoskeleton function. Bioorg Med Chem Lett, 22(3):1459-1463.

[80]MedirattaK, El-SahliS, D'CostaV, et al., 2020. Current progresses and challenges of immunotherapy in triple-negative breast cancer. Cancers (Basel), 12(12):3529.

[81]MehtaAK, KadelS, TownsendMG, et al., 2021. Macrophage biology and mechanisms of immune suppression in breast cancer. Front Immunol, 12:643771.

[82]Mir HassaniZ, NabiuniM, ParivarK, et al., 2021. Melittin inhibits the expression of key genes involved in tumor microenvironment formation by suppressing HIF-1α signaling in breast cancer cells. Med Oncol, 38(7):77.

[83]MittalV, 2018. Epithelial mesenchymal transition in tumor metastasis. Annu Rev Pathol, 13:395-412.

[84]MoghaddamFD, MortazaviP, HamediS, et al., 2020. Apoptotic effects of melittin on 4T1 breast cancer cell line is associated with up regulation of Mfn1 and Drp1 mRNA expression. Anticancer Agents Med Chem, 20(7):790-799.

[85]MorrishE, BrumattiG, SilkeJ, 2020. Future therapeutic directions for Smac-mimetics. Cells, 9(2):406.

[86]MuXZ, WangCC, 2018. Artemisinins—a promising new treatment for systemic lupus erythematosus: a descriptive review. Curr Rheumatol Rep, 20(9):55.

[87]NazimUM, YinHH, ParkSY, 2020. Downregulation of c-FLIP and upregulation of DR-5 by cantharidin sensitizes TRAIL‑mediated apoptosis in prostate cancer cells via autophagy flux. Int J Mol Med, 46(1):280-288.

[88]NedeljkovićM, DamjanovićA, 2019. Mechanisms of chemotherapy resistance in triple-negative breast cancer—how we can rise to the challenge. Cells, 8(9):957.

[89]NiLQ, ChenLL, HuangX, et al., 2020. Combating COVID-19 with integrated traditional Chinese and Western medicine in China. Acta Pharm Sin B, 10(7):1149-1162.

[90]NoonanAM, BunchKP, ChenJQ, et al., 2016. Pharmacodynamic markers and clinical results from the phase 2 study of the SMAC mimetic birinapant in women with relapsed platinum-resistant or -refractory epithelial ovarian cancer. Cancer, 122(4):588-597.

[91]OršolićN, 2012. Bee venom in cancer therapy. Cancer Metastasis Rev, 31(1-2):173-194.

[92]OrtizE, GurrolaGB, SchwartzEF, et al., 2015. Scorpion venom components as potential candidates for drug development. Toxicon, 93:125-135.

[93]OsborneCK, BardouV, HoppTA, et al., 2003. Role of the estrogen receptor coactivator AIB1 (SRC-3) and HER-2/neu in tamoxifen resistance in breast cancer. J Natl Cancer Inst, 95(5):353-361.

[94]PanMS, CaoJ, FanYZ, 2020. Insight into norcantharidin, a small-molecule synthetic compound with potential multi-target anticancer activities. Chin Med, 15:55.

[95]PanYH, ZhengQ, NiWT, et al., 2019. Breaking glucose transporter 1/pyruvate kinase M2 glycolytic loop is required for cantharidin inhibition of metastasis in highly metastatic breast cancer. Front Pharmacol, 10:590.

[96]PatersonRRM, 2008. Cordyceps—a traditional Chinese medicine and another fungal therapeutic biofactory? Phytochemistry, 69(7):1469-1495.

[97]QiFH, LiAY, InagakiY, et al., 2011. Antitumor activity of extracts and compounds from the skin of the toad Bufo bufo gargarizans Cantor. Int Immunopharmacol, 11(3):342-349.

[98]QiWC, ZhouXT, WangJQ, et al., 2020. Cordyceps sinensis polysaccharide inhibits colon cancer cells growth by inducing apoptosis and autophagy flux blockage via mTOR signaling. Carbohydr Polym, 237:116113.

[99]QuanXG, KwakBS, LeeJY, et al., 2020. Cordyceps militaris induces immunogenic cell death and enhances antitumor immunogenic response in breast cancer. Evid Based Complement Alternat Med, 2020:9053274.

[100]RadyI, SiddiquiIA, RadyM, et al., 2017. Melittin, a major peptide component of bee venom, and its conjugates in cancer therapy. Cancer Lett, 402:16-31.

[101]RaveendranR, ChenF, KentB, et al., 2020. Estrone-decorated polyion complex micelles for targeted melittin delivery to hormone-responsive breast cancer cells. Biomacromolecules, 21(3):1222-1233.

[102]RowinskyEK, 2005. Targeted induction of apoptosis in cancer management: the emerging role of tumor necrosis factor-related apoptosis-inducing ligand receptor activating agents. J Clin Oncol, 23(36):9394-9407.

[103]Sarfo-PokuC, EshunO, LeeKH, 2016. Medical application of scorpion venom to breast cancer: a mini-review. Toxicon, 122:109-112.

[104]SeshacharyuluP, PandeyP, DattaK, et al., 2013. Phosphatase: PP2A structural importance, regulation and its aberrant expression in cancer. Cancer Lett, 335(1):9-18.

[105]ShouLM, ZhangQY, LiW, et al., 2013. Cantharidin and norcantharidin inhibit the ability of MCF-7 cells to adhere to platelets via protein kinase C pathway-dependent downregulation of α2 integrin. Oncol Rep, 30(3):‍1059-1066.

[106]SinghSK, SinghS, LillardJW, et al., 2017. Drug delivery approaches for breast cancer. Int J Nanomedicine, 12:6205-6218.

[107]SomanNR, BaldwinSL, HuG, et al., 2009. Molecularly targeted nanocarriers deliver the cytolytic peptide melittin specifically to tumor cells in mice, reducing tumor growth. J Clin Invest, 119(9):2830-2842.

[108]SonDJ, LeeJW, LeeYH, et al., 2007. Therapeutic application of anti-arthritis, pain-releasing, and anti-cancer effects of bee venom and its constituent compounds. Pharmacol Ther, 115(2):246-270.

[109]SongJJ, WangYW, TengMY, et al., 2016. Cordyceps militaris induces tumor cell death via the caspase-dependent mitochondrial pathway in HepG2 and MCF-7 cells. Mol Med Rep, 13(6):5132-5140.

[110]SongMY, WangXF, LuoYJ, et al., 2020. Cantharidin suppresses gastric cancer cell migration/invasion by inhibiting the PI3K/Akt signaling pathway via CCAT1. Chem Biol Interact, 317:108939.

[111]SongXF, ZhangGJ, SunAP, et al., 2012. Scorpion venom component III inhibits cell proliferation by modulating NF-κB activation in human leukemia cells. Exp Ther Med, 4(1):146-150.

[112]SongXZ, ZhangCW, ZhaoMK, et al., 2015. Steroid receptor coactivator-‍3 (SRC-3/AIB1) as a novel therapeutic target in triple negative breast cancer and its inhibition with a phospho-bufalin prodrug. PLoS ONE, 10(10):e0140011.

[113]SuiZG, ZhangLH, HuoYS, et al., 2014. Bioactive components of velvet antlers and their pharmacological properties. J Pharm Biomed Anal, 87:229-240.

[114]SungH, FerlayJ, SiegelRL, et al., 2021. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin, 71(3):209-249.

[115]TariqM, ZhangJQ, LiangGK, et al., 2017. Macrophage polarization: anti-cancer strategies to target tumor-associated macrophage in breast cancer. J Cell Biochem, 118(9):2484-2501.

[116]TianX, YinHZ, ZhangSC, et al., 2014. Bufalin loaded biotinylated chitosan nanoparticles: an efficient drug delivery system for targeted chemotherapy against breast carcinoma. Eur J Pharm Biopharm, 87(3):445-453.

[117]TuGG, ZhanJF, LvQL, et al., 2014. Synthesis and antiproliferative assay of norcantharidin derivatives in cancer cells. Med Chem, 10(4):376-381.

[118]TuliHS, SharmaAK, SandhuSS, et al., 2013. Cordycepin: a bioactive metabolite with therapeutic potential. Life Sci, 93(23):863-869.

[119]VahedSZ, SalehiR, DavaranS, et al., 2017. Liposome-based drug co-delivery systems in cancer cells. Mater Sci Eng C Mater Biol Appl, 71:1327-1341.

[120]van VaerenberghM, CardoenD, FormesynEM, et al., 2013. Extending the honey bee venome with the antimicrobial peptide apidaecin and a protein resembling wasp antigen 5. Insect Mol Biol, 22(2):199-210.

[121]WaksAG, WinerEP, 2019. Breast cancer treatment: a review. JAMA, 321(3):288-300.

[122]WangDT, BergD, BaHX, et al., 2019. Deer antler stem cells are a novel type of cells that sustain full regeneration of a mammalian organ—deer antler. Cell Death Dis, 10(6):443.

[123]WangKL, ChenQ, ShaoYY, et al., 2021. Anticancer activ

[124]ities of TCM and their active components against tumor metastasis. Biomed Pharmacother, 133:111044.

[125]WangRP, HuangSR, ZhouJY, et al., 2014. Synergistic interaction between melittin and chemotherapeutic agents and their possible mechanisms: an experimental research. Chin J Integr Tradit Western Med, 34(2):224-229 (in Chinese).

[126]WangS, FuJL, HaoHF, et al., 2021. Metabolic reprogramming by traditional Chinese medicine and its role in effective cancer therapy. Pharmacol Res, 170:105728.

[127]WangY, LonardDM, YuY, et al., 2014. Bufalin is a potent small-molecule inhibitor of the steroid receptor coactivators SRC-3 and SRC-1. Cancer Res, 74(5):1506-1517.

[128]WehbeR, FrangiehJ, RimaM, et al., 2019. Bee venom: overview of main compounds and bioactivities for therapeutic interests. Molecules, 24(16):2997.

[129]WongSHM, KongWY, FangCM, et al., 2019. The TRAIL to cancer therapy: hindrances and potential solutions. Crit Rev Oncol Hematol, 143:81-94.

[130]XiaoMZ, TianJX, ZhouYN, et al., 2020. Efficacy of Huoxiang Zhengqi dropping pills and Lianhua Qingwen granules in treatment of COVID-19: a randomized controlled trial. Pharmacol Res, 161:105126.

[131]XieSS, SpelminkL, CodemoM, et al., 2016. Cinobufagin modulates human innate immune responses and triggers antibacterial activity. PLoS ONE, 11(8):e0160734.

[132]XieX, WuMY, ShouLM, et al., 2015. Tamoxifen enhances the anticancer effect of cantharidin and norcantharidin in pancreatic cancer cell lines through inhibition of the protein kinase C signaling pathway. Oncol Lett, 9(2):837-844.

[133]XuGG, ZhaoHP, XuJD, et al., 2021. Hard antler extract inhibits invasion and epithelial-mesenchymal transition of triple-negative and Her-2+ breast cancer cells by attenuating nuclear factor-κB signaling. J Ethnopharmacol, 269:113705.

[134]XuJ, TanZC, ShenZY, et al., 2021. Cordyceps cicadae polysaccharides inhibit human cervical cancer hela cells proliferation via apoptosis and cell cycle arrest. Food Chem Toxicol, 148:111971.

[135]YanSC, QuXJ, XuCA, et al., 2012. Down-regulation of Cbl-b by bufalin results in up-regulation of DR4/DR5 and sensitization of TRAIL-induced apoptosis in breast cancer cells. J Cancer Res Clin Oncol, 138(8):1279-1289.

[136]YanSC, LiuYP, QuXJ, et al., 2014a. Bufalin induced apoptosis of MCF-7 breast cancer cells by down-regulating the activity of AKT. J China Med Univ, 43(7):598-601, 611 (in Chinese).

[137]YanSC, QuXJ, XuL, et al., 2014b. Bufalin enhances TRAIL-induced apoptosis by redistributing death receptors in lipid rafts in breast cancer cells. Anticancer Drugs, 25(6):683-689.

[138]YanSC, JiaoX, LiK, et al., 2016a. The mechanism of bufalin and paclitaxel synergistically suppress the proliferation of breast cancer cells. J Mod Oncol, 24(20):3173-3176 (in Chinese).

[139]YanSC, JiaoX, LiK, et al., 2016b. The mechanism of bufalin and cisplatin synergistically suppress the proliferation of breast cancer MCF-7 cells. Chin Clin Oncol, 21(12):1057-1062 (in Chinese).

[140]YangQ, YinYL, YuGJ, et al., 2015. A novel protein with anti-metastasis activity on 4T1 carcinoma from medicinal fungus Cordyceps militaris. Int J Biol Macromol, 80:385-391.

[141]YangXQ, LinP, WangJ, et al., 2021. Purification, characterization and anti-atherosclerotic effects of the polysaccharides from the fruiting body of Cordyceps militaris. Int J Biol Macromol, 181:890-904.

[142]YinSL, ZhangH, JiaLN, et al., 2019. Apoptosis in breast cancer cells MCF-7 induced by norcantharidin through the Wnt/β-catenin signaling pathway. J Shenyang Med Coll, 21(6):500-504 (in Chinese).

[143]YongTQ, ZhangML, ChenDL, et al., 2016. Actions of water extract from Cordyceps militaris in hyperuricemic mice induced by potassium oxonate combined with hypoxanthine. J Ethnopharmacol, 194:403-411.

[144]YuCH, KanSF, PuHF, et al., 2008. Apoptotic signaling in bufalin- and cinobufagin-treated androgen-dependent and -independent human prostate cancer cells. Cancer Sci, 99(12):2467-2476.

[145]YuanX, GajanA, ChuQ, et al., 2018. Developing TRAIL/TRAIL death receptor-based cancer therapies. Cancer Metastasis Rev, 37(4):733-748.

[146]ZhangC, MaK, LiWY, 2019. Cinobufagin suppresses the characteristics of osteosarcoma cancer cells by inhibiting the IL-6-OPN-STAT3 pathway. Drug Des Devel Ther, 13:4075-4090.

[147]ZhangED, LiB, 2004. Resources of Chinese Materia Medica and Conservation of Endangered Wild Animals and Plants. Shanghai Pujiang Education Press, Shanghai, China(in Chinese).

[148]ZhangJH, HongYJ, XiePS, et al., 2020. Spatial lipidomics reveals anticancer mechanisms of bufalin in combination with cinobufagin in tumor-bearing mice. Front Pharmacol, 11:593815.

[149]ZhangP, CuiZ, LiuYS, et al., 2005. Quality evaluation of traditional Chinese drug toad venom from different origins through a simultaneous determination of bufogenins and indole alkaloids by HPLC. Chem Pharm Bull (Tokyo), 53(12):1582-1586.

[150]ZhangS, LiuY, YeY, et al., 2018. Bee venom therapy: potential mechanisms and therapeutic applications. Toxicon, 148:64-73.

[151]ZhangXM, ZhangBF, ZhangPH, et al., 2019. Norcantharidin regulates ERα signaling and tamoxifen resistance via targeting miR-873/CDK3 in breast cancer cells. PLoS ONE, 14(5):e0217181.

[152]ZhangY, LouYN, WangJB, et al., 2020. Research status and molecular mechanism of the traditional Chinese medicine and antitumor therapy combined strategy based on tumor microenvironment. Front Immunol, 11:609705.

[153]ZhaoL, YangGS, BaiH, et al., 2017. NCTD promotes Birinapant-mediated anticancer activity in breast cancer cells by downregulation of c-FLIP. Oncotarget, 8(16):26886-26895.

[154]ZhaoXY, WangXY, WeiQY, et al., 2020. Potency and selectivity of SMAC/DIABLO mimetics in solid tumor therapy. Cells, 9(4):1012.

[155]ZhaoZY, LiYD, ZhouLY, et al., 2021. Prevention and treatment of COVID-19 using traditional Chinese medicine: a review. Phytomedicine, 85:153308.

[156]ZhengKX, LiQL, LinDD, et al., 2020. Peptidomic analysis of pilose antler and its inhibitory effect on triple-negative breast cancer at multiple sites. Food Funct, 11(9):‍7481-7494.

[157]ZhuL, ChenYX, WeiC, et al., 2018. Anti-proliferative and pro-apoptotic effects of cinobufagin on human breast cancer MCF-7 cells and its molecular mechanism. Nat Prod Res, 32(4):493-497.

[158]ZhuYX, ZhuXD, TangCJ, et al., 2021. Progress and challenges of immunotherapy in triple-negative breast cancer. Biochim Biophys Acta Rev Cancer, 1876(2):188593.

[159]ZouZZ, LuoXY, NiePP, et al., 2016. Inhibition of SRC-3 enhances sensitivity of human cancer cells to histone deacetylase inhibitors. Biochem Biophys Res Commun, 478(1):227-233.

Open peer comments: Debate/Discuss/Question/Opinion

<1>

Please provide your name, email address and a comment





Journal of Zhejiang University-SCIENCE, 38 Zheda Road, Hangzhou 310027, China
Tel: +86-571-87952783; E-mail: cjzhang@zju.edu.cn
Copyright © 2000 - 2022 Journal of Zhejiang University-SCIENCE